James Lanthier

Biopharma R&D company Mindset Pharma Inc. (OTCQB: MSSTF) has performed preclinical screening studies and selected MSP-2020 as the lead psychedelic drug clinical candidate and MSP-2003 as the second backup drug candidate, both belonging to its Family 2 next-gen psychedelic drug program done in...

Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc. (OTCQB: MSSTF) for an exclusive intellectual property license related to...

Biotech drug discovery firm Mindset Pharma Inc. (OTCQB: MSSTF) develops next-generation psychedelic and non-psychedelic medicines for neuropsychiatric and neurological disorders. To pursue their goal it received scientific advice from the UK Medicines and Healthcare Products Regulatory Agency...

Psychedelics R&D company Mindset Pharma (OTCQB: MSSTF) has filed no less than 16 national applications, including countries within the main South East Asian markets, for one of its key families of next-generation psychedelic compounds. The company recently announced the creation of three...

Mindset Pharma Inc. (OTCQB: MSSTF), a company producing psychedelic and non-psychedelic drugs for mental health conditions has recently identified three additional families of highly novel, non-tryptamine psychedelic compounds. Since its formation, Mindset has the goal of taking drug discovery...

In the process of creating optimized next-generation psychedelic medicines for neurological and psychiatric disorders, drug discovery and development company Mindset Pharma Inc. (OTCQB: MSSTF) has developed a novel, patent-pending, intranasal program formulation technology expected to deliver...

Mindset Pharma Inc. (OTCQB: MSSTF), a drug discovery and development company creating next-generation psychedelic medicines for treating neurological and psychiatric disorders, has signed up for a research collaboration with the Centre for Addiction and Mental Health (CAMH), a health teaching and...

Mindset Pharma Inc. (OTCQB: MSSTF), a drug discovery & development company creating psychedelic medicines to treat neurological and psychiatric disorders, is currently working on four novel families of next-generation psychedelic compounds, as well as an innovative process to chemically...